The efficacy of these approaches in PDH-deficient-related mitochondrial diseases has not been investigated yet but our data pave the way for further studies evaluating whether the interplay between the PDC and the Elongator complex also represents a new avenue for therapeutic intervention. The gene discussed is PDP1; the disease is mitochondrial disease.